Your browser doesn't support javascript.
loading
MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy.
Beloueche-Babari, Mounia; Wantuch, Slawomir; Casals Galobart, Teresa; Koniordou, Markella; Parkes, Harold G; Arunan, Vaitha; Chung, Yuen-Li; Eykyn, Thomas R; Smith, Paul D; Leach, Martin O.
Afiliación
  • Beloueche-Babari M; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, United Kingdom. mounia.beloueche-babari@icr.ac.uk.
  • Wantuch S; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Casals Galobart T; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Koniordou M; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Parkes HG; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Arunan V; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Chung YL; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Eykyn TR; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Smith PD; AstraZeneca, Cancer Biosciences, Cancer Research UK Cambridge Institute, Cambridge, United Kingdom.
  • Leach MO; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Cancer Res ; 77(21): 5913-5924, 2017 11 01.
Article en En | MEDLINE | ID: mdl-28923861
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinonas / Tiofenos / Protocolos de Quimioterapia Combinada Antineoplásica / Transportadores de Ácidos Monocarboxílicos / Simportadores / Linfoma / Mitocondrias Límite: Animals / Female / Humans Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinonas / Tiofenos / Protocolos de Quimioterapia Combinada Antineoplásica / Transportadores de Ácidos Monocarboxílicos / Simportadores / Linfoma / Mitocondrias Límite: Animals / Female / Humans Idioma: En Año: 2017 Tipo del documento: Article